AKORN INC
10-Q, EX-11.1, 2000-11-14
PHARMACEUTICAL PREPARATIONS
Previous: AKORN INC, 10-Q, 2000-11-14
Next: AKORN INC, 10-Q, EX-27, 2000-11-14



<PAGE>   1
                                  AKORN, INC.
                                  EXHIBIT 11.1

                      COMPUTATION OF NET INCOME PER SHARE
                     (IN THOUSANDS, EXCEPT PER SHARE DATA)



<TABLE>
<CAPTION>
                                                     Three Months Ended                Nine Months Ended
                                                        September 30,                    September 30,
                                                 --------------------------       ---------------------------

                                                    2000             1999            2000            1999
                                                 ----------       ---------       ----------      -----------

<S>                                                 <C>            <C>             <C>             <C>
Earnings:
  Income applicable to common stock                $    415       $  1,702         $ 4,393         $  4,835
                                                   ========       ========         =======         ========

  Weighted average number of shares
      outstanding                                    19,081         18,477          18,961           18,273

Net income per share - basic                       $   0.02       $   0.09         $  0.23         $   0.26

  Additional shares assuming conversion
      of options and warrants                           932            404             843              429
                                                   --------       --------         -------         --------
Pro forma shares                                     20,013         18,881          19,804           18,702
                                                   ========       ========         =======         ========

Net income per share - diluted                     $   0.02       $   0.09         $  0.22         $   0.26
                                                   ========       ========         =======         ========

</TABLE>


© 2022 IncJournal is not affiliated with or endorsed by the U.S. Securities and Exchange Commission